Contact us

Small Batch Size CDMO Companies
Small Batch Size Contract Manufacturing Services

Your Trusted Partners for Small Batch Size Contract Manufacturing and Development

Applied Filters:Small×Clear All
Showing 157 facilities
SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland

Senn Chemicals

Swiss peptide and peptide intermediates R&D site with SPPS, LPPS, hybrid synthesis, kilo lab scale up, purification and analytics.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

CATEGORY / PRODUCT: COSMETICS, CHEMICAL-SYNTHETIC, SERVICES, PARTICLE ENGINEERING

BATCH SIZE: Small

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland

Senn Chemicals

Small scale GMP peptide and organic synthesis lab for clinical, niche and high value projects requiring flexible cGMP production.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING

BATCH SIZE: Small

SENN India | Non-GMP Plant | Hyderabad, India
India

SENN India | Non-GMP Plant | Hyderabad, India

Senn Chemicals

Large scale non GMP manufacturing site for peptide intermediates, organic synthesis, LPPS operations and scale up production.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: APAC

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, CHEMICAL-SYNTHETIC, SERVICES, PARTICLE ENGINEERING

SENN India | R&D Lab | Hyderabad, India
India

SENN India | R&D Lab | Hyderabad, India

Senn Chemicals

R&D centre for peptide and organic chemistry with SPPS, purification, lyophilisation, analytics and particle engineering support.

SERVICES: Logistics, Development services, Analytical / QC services, Quality Assurance services, Packaging

REGION: APAC

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING

BATCH SIZE: Small

Laboratorios Grifols | Barcelona Plant
Spain

Laboratorios Grifols | Barcelona Plant

Grifols International

Sterile manufacturing solutions (small molecules) in flexible bags and vials.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

White Raven - Legiapark
Belgium

White Raven - Legiapark

White Raven

Fill and finish site dedicated to GMP Formulation and the Aseptic filling of Sterile Liquid Injectables.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: EMA (EU)

REGION: Europe

USE: Human

BSL (Biological Safety Level): 1, 2

SERVICES: Manufacturing services, Packaging

BATCH SIZE: Small, Medium

COMPLIANCE: EMA (EU GMP)

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

Sylentis
Spain

Sylentis

Sylentis

Oligonucleotide manufacturer.

COMPLIANCE: ICH, FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

MARKETS: EMA (EU), FDA (USA)

REGION: Europe

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: OLIGONUCLEOTIDES

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

VIVEbiotech
Spain

VIVEbiotech

VIVEbiotech

Your leading GMP-certified CDMO exclusively dedicated to the production of lentiviral vectors.

MARKETS: EMA (EU), FDA (USA), MHRA (UK)

REGION: Europe

COMPLIANCE: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

CATEGORY / PRODUCT: BIOLOGICS

Viswa Laboratories Pvt Ltd
India

Viswa Laboratories Pvt Ltd

Viswa Laboratories Private Limited

CRAMS/CDMO, APIs, Intermediates and specialty chemicals.

MARKETS: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, CDSCO (India)

REGION: APAC

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (R) Respiratory system

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: World Health Organization (GMP / HACCP)

Pharmaron API Commercial Synthesis Shaoxing (China)
China

Pharmaron API Commercial Synthesis Shaoxing (China)

Pharmaron

Commercial API Small Molecules /Peptides Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: NMPA (China), FDA (USA)

REGION: APAC

COMPLIANCE: FDA (cGMP), ISO, NMPA (China GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

Pharmaron API Commercial Synthesis Cramlington (UK)
United Kingdom

Pharmaron API Commercial Synthesis Cramlington (UK)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Pharmaron API Commercial Synthesis Coventry (US)
United States

Pharmaron API Commercial Synthesis Coventry (US)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)

COMPLIANCE: FDA (cGMP), ISO, ECOVADIS

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+79 more facilities

Create free account

In today’s pharma and biotech landscape, not every product requires — or can support — large-scale production. Early-stage clinical materials, orphan drugs, and personalized medicines demand flexibility, precision, and cost-efficiency. That’s why working with experienced small batch size CDMO companies is critical for efficient, GMP-compliant manufacturing at lower volumes.

Through tailored small batch size contract manufacturing solutions, these CDMOs help you navigate early development, clinical supply, and niche commercial production with minimal waste, fast timelines, and full regulatory control.

How to Choose Small Batch Size CDMO Companies

When evaluating small batch size CDMO companies, consider these key factors:

  • Batch size flexibility: Ability to handle grams to kilograms and a range of batch volumes
  • Dedicated equipment: For small-scale production (mini reactors, lab-scale blenders, single-use systems)
  • Speed and responsiveness: For rapid project turnaround
  • Segregated lines: Or suites for high-potency, sterile, or personalized formulations
  • Clinical trial material (CTM) experience
  • Regulatory expertise: For GMP documentation, QP release, and global submissions
  • Tech transfer readiness: For eventual scale-up if needed

A nimble CDMO should combine technical quality with operational agility.

Key Services Offered by Small Batch Size Contract Manufacturers

Leading small batch size contract manufacturing providers typically offer:

  • Formulation development: And feasibility assessment for low-volume products
  • Analytical method development: And stability testing
  • Small-scale blending, granulation, encapsulation, and compression
  • Sterile fill-finish: For small-volume liquid or lyophilized products
  • Personalized packaging: For individualized therapies or low-volume SKUs
  • Batch documentation: Aligned with GMP and ICH standards
  • Clinical trial supply: Manufacturing and distribution
  • Support for rare disease, pediatric, and personalized medicine pipelines

These services are ideal for companies looking to reduce risk and conserve API during early development or for specialized markets.

Advantages of Partnering

Working with specialized small batch size CDMO companies offers major advantages:

  • Lower cost of entry: For early-stage and low-volume products
  • Minimal waste: And better API utilization
  • Rapid execution: With shorter setup and turnaround times
  • Custom project management: And hands-on technical support
  • Scalable pathways: To larger production when needed

This approach is ideal for innovators prioritizing speed, flexibility, and regulatory compliance over high-volume output.

Small Batch Size CDMO Companies

Some of the most trusted small batch size CDMO companies include:

  • Liof Pharma: Reliable small batch size CDMO partner for clinical aseptic manufacturing and lyophilization of biologics and injectable drugs. [See CDMO profile]

  • Cultiply: Small batch size product CDMO specializing production and purification processes for recombinant proteins, enzymes, DNA and other bioderived products. [See CDMO profile]

  • BDI biotech: We work as an R&D department specialized in strain and bioprocess development, scale-up and batches production. [See CDMO profile]

  • Cenexi: Clinical CDMO specializing in clinical manufacturing and sterile highly potent injectables, mainly for cancer. [See CDMO profile]

  • I+Med: Developer and manufacturer of new drug products with controlled release technologies. [See CDMO profile]

  • ASCIL Biopharm: A GMP facility fully equipped for R&D and pharmaceutical development, including laboratories and a pilot plant for technical and clinical batches of sterile products. [See CDMO profile]

  • VIVUNT: Small batch size for investigational sterile oncology drugs. [See CDMO profile]

  • Grifols: Clinical manufacturing solutions for flexible bags and vials. [See CDMO profile]

  • Lannet CDMO: Main manufacturing site in Seymour, Indiana, with capabilities for Oral Solid Dose (OSD) and liquids. [See CDMO profile]

  • Viswa: CRAMS/CDMO, APIs, intermediates and specialty chemicals. [See CDMO profile]

  • FAES FARMA: Developer and manufacturer of human investigational products. [See CDMO profile]

  • Pharmaron: Small Molecule (RSM/APIs) commercial facility. [See CDMO profile]

  • Shilpa Biologicals: CDMO supporting process development, CLD, GMP, formulation, analytical development, DS, DP, fill-finish, and packaging. [See CDMO profile]

  • Mabion: Fully integrated clinical CDMO offering development and GMP small batch size manufacturing of mAbs and recombinant protein-based products. [See CDMO profile]

  • Reig Jofre: Injectable (lyo & liquid) and liquid manufacturing facilities. [See CDMO profile]

  • VIVEbiotech: Leading GMP-certified CDMO exclusively for lentiviral vectors. [See CDMO profile]

  • 53Biologics Production Plant: specialized in decoding biologics production, from DNA to proteins, providing from preclinical to cGMP manufacturing. [See CDMO profile]

  • PHARMALOOP S.L. - a Salvat Company: Fully integrated CDMO solutions for BFS, sterile multidose, non-sterile multidose, sachets, capsules and tablets. [See CDMO profile]

  • ChemCon GmbH: specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. [See CDMO profile]

  • HISTOCELL S.L: develops and manufactures cell therapies (iPSCs, MSCs, secretomes, exosomes) and medical devices and dermocosmetics. [See CDMO profile]

  • Laboratori Alchemia SRL: production from lab scale for synthetically complex products up to several hundred kilograms per year. [See CDMO profile]

  • CDM Lavoisier: specialized in manufacturing glass ampoules, glass vials and plastic (BFS) ampoules. [See CDMO profile]

  • Aenova Group: Competence center for conventional solids and clinical services. [See CDMO profile]

  • Actylis Eugene: Chemical process discovery, development, cGMP and commercial manufacturing services. [See CDMO profile]

  • Cambrex: early development of small-molecule pharmaceutical products in an integrated DS/DP facility. [See CDMO profile]

  • HIPRA BIOTECH SERVICES: End-to-end capabilities from cell line development to commercial manufacturing. [See CDMO profile]

  • Skyepharma: development and delivery of oral technologies for pharma, biotech and consumer health. [See CDMO profile]

  • Ophtapharm, a Sentiss Company: Ophthalmic & otic solutions, suspensions, emulsions, ointments and gels – FDA-approved facility. [See CDMO profile]

  • CARBOGEN AMCIS: Highly potent APIs development and small-scale cGMP production including chromatography and lyophilization. [See CDMO profile]

  • Sichuan Huiyu Pharmaceuticals Co., Ltd: API and formulation manufacturing with integrated R&D center. [See CDMO profile]

  • AdhexPharma SAS: CDMO for transdermal patches and oromucosal films. [See CDMO profile]

  • Sylentis: Oligonucleotide manufacturer. [See CDMO profile]

  • Apeloa Pharmaceutical Co., Ltd: development & manufacturing of APIs, intermediates and registered starting materials. [See CDMO profile]

  • Lukas Heil-Betriebsstätte: GMP facility for sterile/aseptic liquids, especially glass ampoules. [See CDMO profile]

  • Glatt Pharmaceutical Services GmbH Co. & KG: cGMP CDMO for complex oral solid dosage forms. [See CDMO profile]

  • Darnytsia Kyiv: CMO providing reliable, compliant and innovative solutions. [See CDMO profile]

  • Rodon Biologics: Biopharmaceutical development services for third parties. [See CDMO profile]

  • Basic Pharma Manufacturing: Analytical testing and regulatory support tailored to client needs. [See CDMO profile]

  • White Raven: Fill & finish site for GMP formulation and aseptic filling of sterile injectables. [See CDMO profile]

  • BAG Health Care: Parenteral F&F for vials in small to mid-sized batches. [See CDMO profile]

  • Adragos Pharma: 100+ years providing customer-focused manufacturing. [See CDMO profile]

  • Cellex Cell Professionals: CGT CDMO cell manufacturing plant & collection center. [See CDMO profile]

  • Sidefarma: EU-quality manufacturing of small & medium batches for regulated markets. [See CDMO profile]

  • Ascendia Pharmaceutical Solutions: GMP CDMO for sterile & non-sterile manufacturing, formulation, and analytical services. [See CDMO profile]

  • TRADICHEM INDUSTRIAL SERVICES: API compaction & granulation using Hipering patented technology. [See CDMO profile]

Related Information

Let MAI CDMO Help You Find the Right Small Batch Size CDMO Partner

At MAI CDMO, we connect emerging and established life sciences companies with leading small batch size CDMO companies offering tailored, GMP-compliant small batch size contract manufacturing solutions. Whether you’re launching a clinical trial, preparing a limited-market therapy, or testing a new formulation, our partners deliver flexibility without sacrificing quality.

Need precision manufacturing at manageable volumes? Contact us today and let’s find the perfect CDMO match for your needs.